Radius Health (Radius Health) Total Assets : $154.4 Mil (As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Radius Health Total Assets?

Radius Health's Total Assets for the quarter that ended in Jun. 2022 was $154.4 Mil.

Total Assets is connected with ROA %. Radius Health's annualized ROA % for the quarter that ended in Jun. 2022 was -33.01%. Total Assets is also linked to Revenue through Asset Turnover. Radius Health's Asset Turnover for the quarter that ended in Jun. 2022 was 0.38.

Radius Health Total Assets Historical Data

The historical data trend for Radius Health's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radius Health Total Assets Chart

Radius Health Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Assets

Get a 7-Day Free Trial

461.66

286.96

219.15

191.58

181.54

Radius Health Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Total Assets	Get a 7-Day Free Trial															192.87	186.18	181.54	154.15	154.44

Radius Health Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Radius Health's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	-252.304	+	433.846
	=	181.5

Radius Health's Total Assets for the quarter that ended in Jun. 2022 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2022 )	+	Total Liabilities (Q: Jun. 2022 )
	=	-273.403	+	427.843
	=	154.4

Radius Health (NAS:RDUS) Total Assets Explanation

Total Assets is connected with ROA %.

Radius Health's annualized ROA % for the quarter that ended in Jun. 2022 is

ROA %	=	Net Income (Q: Jun. 2022 )	/	( (Total Assets (Q: Mar. 2022 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
	=	-50.932	/	( (154.148	+	154.44)	/ 2 )
	=	-50.932	/	154.294
	=	-33.01 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Radius Health's Asset Turnover for the quarter that ended in Jun. 2022 is

	Asset Turnover
=	Revenue (Q: Jun. 2022 )	/	( (Total Assets (Q: Mar. 2022 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
=	58.285	/	( (154.148	+	154.44)	/ 2 )
=	58.285	/	154.294
=	0.38

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Radius Health Total Assets Related Terms

Thank you for viewing the detailed overview of Radius Health's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Radius Health (Radius Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radius Health Inc (NAS:RDUS) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Boston Wharf Road, 7th Floor, Boston, MA, USA, 02210

Website

https://www.radiuspharm.com

Radius Health Inc is an integrated biopharmaceutical company. It develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company's product, TYMLOS, is for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The product pipeline of the company includes Abaloparatide-patch for the treatment of postmenopausal women with osteoporosis, Elacestrant, and RAD140. It primarily operates the business in the United States of America and generates key revenue from the sales of TYMLOS.

Executives

Willard H Dere	director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Jean Pierre Garnier	director	UNITED TECHNOLOGIES CORP, 10 FARM SPRINGS ROAD, FARMINGTON CT 06032
Von Eschenbach Andrew C.	director	C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Jennifer Jarrett	director	C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105
Cathy Friedman	director	C/O INNOVIVA, INC., 2000 SIERRA POINT PARKWAY, SUITE 500, BRISBANE CA 94005
Machelle Sanders	director	C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560
G. Kelly Martin	director, officer: CEO and President	C/O NOVAN, INC., 4105 HOPSON RD, MORRISVILLE NC 27560
Sean Murphy	director	C/O NOVAN, INC., 4222 EMPEROR BOULEVAND, SUITE 200, DURHAM NC 27703
Owen Hughes	director	C/O RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, BOSTON MA 02139
Elizabeth Messersmith	officer: Senior Vice President	22 BOSTON WHARF ROAD 7TH FLOOR BOSTON MA 02210
Danielle Holtschlag	officer: Vice President, Sales	22 BOSTON WHARF ROAD 7TH FLOOR BOSTON MA 02210
Chhaya Shah	officer: Chief Business Officer	22 BOSTON WHARF ROAD 7TH FLOOR BOSTON MA 02210
Susan Vissers Lisa	director	22 BOSTON WHARF ROAD 7TH FLOOR BOSTON MA 02210
Rubric Capital Management Lp	10 percent owner	155 EAST 44TH ST, SUITE 1630, NEW YORK NY 10017
Biotech Target N V	10 percent owner	ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1, CURACAO, WILLEMSTAD P8 000000